Pharmaceutical composition for Inhalation comprising aclidinium, lactose, providing a dose of 322 UG Free Base and about 140 ug of aclidinium bromide； a method for treating a Respiratory condition selected Asthma and COPD； use of the composition, and an inhalation device Calibration that includes dry powder
A pharmaceutical composition for inhalation comprising aclidinium in the form of a dry powder of a pharmaceutically acceptable salt in admixture with a pharmaceutically acceptable dry powder carrier, providing a delivered dose of aclidinium equivalent to about 322 micrograms aclidinium free base.<；p>；La solicitud 201403211 describe a una composició；n farmacé；utica en forma de polvo seco para inhalació；n que comprende aclidinio o una sal farmacé；uticamente aceptable del mismo en mezcla con un excipiente inerte farmacé；uticamente aceptable； y su uso para preparar un medicamento para el tratamiento de una enfermedad respiratoria, tales como asma y EPOC.<；/p>；
